Long-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation.
about
Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive reviewCharacterization of a spontaneous retinal neovascular mouse modelShort-term efficacy of intravitreal Aflibercept injections for retinal angiomatous proliferation.Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).Angiographic results of retinal-retinal anastomosis and retinal-choroidal anastomosis after treatments in eyes with retinal angiomatous proliferation.Ranibizumab in monotherapy and combined with photodynamic therapy for retinal angiomatous proliferation.Neovascular age-related macular degeneration.Treating the untreatable patient: current options for the management of treatment-resistant neovascular age-related macular degeneration.Effect of photodynamic therapy (PDT), posterior subtenon injection of triamcinolone acetonide with PDT, and intravitreal injection of ranibizumab with PDT for retinal angiomatous proliferation.Treatment of Bilateral Retinal Angiomatous Proliferation with Anti-vascular Endothelial Growth Factor: 12-Month Outcome.Two-year results of combined intravitreal anti-VEGF agents and photodynamic therapy for retinal angiomatous proliferation.Visual and morphological outcomes of bevacizumab (Avastin®) versus ranibizumab (Lucentis®) treatment for retinal angiomatous proliferation.Intravitreal bevacizumab versus ranibizumab for the treatment of retinal angiomatous proliferation.[Retinal angiomatous proliferation with associated pigment epithelium detachment: anti-VEGF therapy].
P2860
Q26744068-E30E8F4B-617F-46BB-A141-D9610FB7648DQ27312714-BF4C220E-55ED-4EE5-8C82-21CA7F6A9A16Q33846379-6A90EE6D-94D6-4D80-975A-043B01EE4BDEQ35872677-6B7EACD1-C7FB-45B8-96D3-3EE19F3A8E90Q36222187-7D941C9D-8040-4D75-9037-5B81896BD507Q36924497-905B4F9E-4A25-4E98-94EB-742EE2E6298AQ38003861-A9F0F910-F01F-4DBC-8105-AE6B8280A121Q38219895-A2D04A81-7348-446A-8F2D-3A461D2AA6B6Q41588049-B1A1A573-EEB5-4240-A073-354448010B7DQ42204337-D2A60E4C-23E2-481A-BC49-CE10A4E36E7FQ43437549-29ACCBC0-5339-4A4E-BABD-E926FD24DBBCQ50498550-2DF338D9-CC7A-45D6-9A74-D07FABF96A38Q50511227-674E46F5-4FE7-40FE-A558-41E234097431Q50549303-64FE8C7C-FC26-4934-A454-50F580D04983
P2860
Long-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Long-term visual and anatomica ...... nal angiomatous proliferation.
@ast
Long-term visual and anatomica ...... nal angiomatous proliferation.
@en
type
label
Long-term visual and anatomica ...... nal angiomatous proliferation.
@ast
Long-term visual and anatomica ...... nal angiomatous proliferation.
@en
prefLabel
Long-term visual and anatomica ...... nal angiomatous proliferation.
@ast
Long-term visual and anatomica ...... nal angiomatous proliferation.
@en
P2093
P2860
P356
P1476
Long-term visual and anatomica ...... inal angiomatous proliferation
@en
P2093
Laurie Dustin
Pearse A Keane
Srinivas R Sadda
Tarek S Hemeida
P2860
P304
P356
10.1136/BJO.2009.167627
P407
P50
P577
2009-10-23T00:00:00Z